These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1539334

  • 1. Applicability of antimyeloid monoclonal antibodies (L4F3, 1G10) to autologous bone marrow transplantation for patients with acute myelogenous leukemia.
    Takahashi M, Maruyama S, Moriyama Y, Shibata A.
    Transplant Proc; 1992 Feb; 24(1):416-8. PubMed ID: 1539334
    [No Abstract] [Full Text] [Related]

  • 2. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts.
    Vervoordeldonk SF, Merle PA, Steenbergen EJ, van Leeuwen EF, von dem Borne AE, Slaper-Cortenbach IC.
    Prog Clin Biol Res; 1994 Feb; 389():601-9. PubMed ID: 7700926
    [No Abstract] [Full Text] [Related]

  • 3. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
    Guyotat D, Shi ZH, Campos L, Rabat M, Bonnier S, Poncelet P, Laurent JC, Fiere D.
    Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
    [Abstract] [Full Text] [Related]

  • 4. Autologous bone marrow transplantation for acute myeloid leukemia using monoclonal antibody-purged bone marrow.
    Ball ED, Mills L, Hurd D, McMillan R, Gingrich R.
    Prog Clin Biol Res; 1992 Dec; 377():97-110; discussion 111. PubMed ID: 1438450
    [No Abstract] [Full Text] [Related]

  • 5. Effects of anti-myeloid antibodies on the generation of hematopoietic colony-forming units in long-term bone marrow culture.
    Ball ED, Keefe KA, McDermott JM.
    Bone Marrow Transplant; 1989 May; 4(3):309-15. PubMed ID: 2659116
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of bone marrow purging in AML using monoclonal antibodies and complement.
    Mills LE, Ball ED, Howell AL, Cornwell GG, Thompson L, Spruce W, Miller WE, McMillan R.
    Prog Clin Biol Res; 1990 May; 333():165-70. PubMed ID: 2308980
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Continuous infusion of complement by an automated cell processor enhances cytotoxicity of monoclonal antibody sensitized leukemia cells.
    Howell AL, Fogg-Leach M, Davis BH, Ball ED.
    Bone Marrow Transplant; 1989 May; 4(3):317-22. PubMed ID: 2659117
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Monoclonal antibody purging and autologous bone marrow transplantation in acute myelogenous leukemia in complete remission.
    De Fabritiis P, Ferrero D, Sandrelli A, Tarella C, Meloni G, Pulsoni A, Pregno P, Badoni R, De Felice L, Gallo E.
    Bone Marrow Transplant; 1989 Nov; 4(6):669-74. PubMed ID: 2819285
    [Abstract] [Full Text] [Related]

  • 14. Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemia.
    Bishop MR, Warkentin PI, Jackson JD, Bayever E, Iversen PL, Whalen VI, Lastovica J, Haines K, Kessinger A.
    Prog Clin Biol Res; 1994 Nov; 389():183-7. PubMed ID: 7700901
    [No Abstract] [Full Text] [Related]

  • 15. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
    Lemoli RM, Gasparetto C, Scheinberg DA, Moore MA, Clarkson BD, Gulati SC.
    Blood; 1991 Apr 15; 77(8):1829-36. PubMed ID: 2015406
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal antibodies to carbohydrate antigens in autologous bone marrow transplantation.
    Ball ED, Howell AL.
    J Cell Biochem; 1988 Apr 15; 36(4):445-52. PubMed ID: 3288649
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V.
    Exp Hematol; 1992 Mar 15; 20(3):328-33. PubMed ID: 1568448
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
    Sao H, Morishima Y, Ueda R, Yoshikawa S, Kodera Y, Ohno R, Takahashi T.
    Jpn J Cancer Res; 1985 Dec 15; 76(12):1212-21. PubMed ID: 3937833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.